> top > docs > PMC:7228307 > spans > 346-676 > annotations

PMC:7228307 / 346-676 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
21 237-241 Gene denotes FcγR Gene:2213

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T9 237-239 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T3 10-18 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224
T4 251-259 Chemical denotes effector http://purl.obolibrary.org/obo/CHEBI_35224

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T3 19-28 http://purl.obolibrary.org/obo/BFO_0000034 denotes functions
T4 91-100 http://purl.obolibrary.org/obo/IDO_0000528 denotes pathogens

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
21 237-241 Gene denotes FcγR Gene:2213

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T7 102-287 Sentence denotes More than 100 therapeutic monoclonal antibodies (mAbs) are approved or in late stage clinical trials, many of which harness the potent FcγR‐mediated effector systems to varying degrees.

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T7 102-287 Sentence denotes More than 100 therapeutic monoclonal antibodies (mAbs) are approved or in late stage clinical trials, many of which harness the potent FcγR‐mediated effector systems to varying degrees.